BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Prognosis
160 results:

  • 1. ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates.
    Zhang R; Zhu G; Li Z; Meng Z; Huang H; Ding C; Wang Y; Chen C; Li Y; Liu H; Chen J
    Front Immunol; 2024; 15():1382231. PubMed ID: 38646528
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Suppression of NSCLC progression via the co-administration of Danusertib, an AURK inhibitor, and KRIBB11, an HSF1 inhibitor.
    Zhang X; Lei Y; Chen X; He J; Liu Z; Zhu W; Xu Y; Jin X
    Biochem Pharmacol; 2024 May; 223():116155. PubMed ID: 38521474
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Naringenin nanoparticles targeting cyclin B1 suppress the progression of rheumatoid arthritis-associated lung cancer by inhibiting fibroblast-to-myofibroblast transition.
    Wang X; Zhang X; Liu Z; Zhao N; Li X; Su P; Zheng G; Zhang X; Wang H; Zhang Y
    Int J Biochem Cell Biol; 2024 Apr; 169():106557. PubMed ID: 38460905
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Is there a prognostic difference among stage I lung adenocarcinoma patients with different BRAF-mutation status?
    Ma SS; Wang RR; Peng Q; Liu Y; Qian JY; Li MJ; Li K; Huang ZY; Wu LL; Xie D
    Thorac Cancer; 2024 Mar; 15(9):715-721. PubMed ID: 38362771
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.
    Zhou YJ; Yang ML; He X; Gu HY; Ren JH; Cheng ST; Fu Z; Zhang ZZ; Chen J
    J Exp Clin Cancer Res; 2024 Feb; 43(1):45. PubMed ID: 38326908
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
    Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
    BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
    Sun XY; Wang CQ; Mao Y; Zhang ZQ; Cui J; Dong XN; Wang HB
    Clin Breast Cancer; 2024 Apr; 24(3):e167-e176. PubMed ID: 38212189
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity.
    Yuan T; Zeng C; Liu J; Zhao C; Ge F; Li Y; Qian M; Du J; Wang W; Li Y; Liu Y; Dai X; Zhou J; Chen X; Ma S; Zhu H; He Q; Yang B
    Signal Transduct Target Ther; 2024 Jan; 9(1):11. PubMed ID: 38177135
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comprehensive study of clinicopathological and immune cell infiltration and lactate dehydrogenase expression in patients with thymic epithelial tumours.
    Ying J; Huang Y; Ye X; Zhang Y; Yao Q; Wang J; Yang X; Yu C; Guo Y; Zhang X; Lv Q; Wang C; Mao W; Zhao A
    Int Immunopharmacol; 2024 Jan; 126():111205. PubMed ID: 38029550
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Research Progress of BRAF Fusion in Non-small Cell lung cancer].
    Xiao P; Zhong D
    Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):782-788. PubMed ID: 37989341
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors.
    Dai P; Xiong L; Wei Y; Wei X; Zhou X; Zhao J; Tang H
    Sci Rep; 2023 Sep; 13(1):16226. PubMed ID: 37758792
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
    Matsuda N; Yamamoto H; Habu T; Iwata K; Matsubara K; Tanaka S; Hashimoto K; Shien K; Suzawa K; Miyoshi K; Toji T; Okazaki M; Sugimoto S; Takahashi K; Toyooka S
    Ann Surg Oncol; 2023 Dec; 30(13):8727-8734. PubMed ID: 37658268
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification and validation of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with lung adenocarcinoma.
    Li C; Yuan Y; Jiang X; Wang Q
    Sci Rep; 2023 Aug; 13(1):13568. PubMed ID: 37604869
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A subset of VEGFR-TKIs activates AMPK in LKB1-mutant lung cancer.
    Yang L; Zhang Q; Xiong Y; Dang Z; Xiao H; Chen Q; Dai X; Zhang L; Zhu J; Wang D; Li M
    Cancer Sci; 2023 Apr; 114(4):1651-1662. PubMed ID: 36459496
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma.
    Niu J; Yan T; Guo W; Wang W; Ren T; Huang Y; Zhao Z; Yu Y; Chen C; Huang Q; Lou J; Guo L
    Autophagy; 2023 Jun; 19(6):1693-1710. PubMed ID: 36451342
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma associated with coeliac disease.
    McNally E; Cronje L; Fabre A; Moloney E
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36396325
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma.
    Gesmundo I; Pedrolli F; Vitale N; Bertoldo A; Orlando G; Banfi D; Granato G; Kasarla R; Balzola F; Deaglio S; Cai R; Sha W; Papotti M; Ghigo E; Schally AV; Granata R
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232554
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Characteristics of the immune microenvironment and their clinical significance in non-small cell lung cancer patients with ALK-rearranged mutation.
    Zhang B; Zeng J; Zhang H; Zhu S; Wang H; He J; Yang L; Zhou N; Zu L; Xu X; Song Z; Xu S
    Front Immunol; 2022; 13():974581. PubMed ID: 36159860
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. RNF126 contributes to stem cell-like properties and metastasis in hepatocellular carcinoma through ubiquitination and degradation of LKB1.
    Huang J; Li Y; Zheng M; He H; Xu D; Tian D
    Hum Cell; 2022 Nov; 35(6):1869-1884. PubMed ID: 36068398
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Distinct cellular immune profiles in lung adenocarcinoma manifesting as pure ground glass opacity versus solid nodules.
    Qu R; Ye F; Hu S; Wang B; Qin S; Xiong J; Fu X; Li L; Cai Y
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3775-3788. PubMed ID: 35986758
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.